Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Evaluation of the Feasibility of Developing Personalized Breast Cancer Radiotherapy Assistive Device With Three-dimensional Printing Secondary IDs:

NCT04929197 is registered in ClinicalTrials.gov with Taipei Medical University Hospital as lead sponsor.

NCT NCT04929197
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04929197 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Evaluation of the Feasibility of Developing Personalized Breast Cancer Radiotherapy Assistive Device With Three-dimensional Printing Secondary IDs:
Lead sponsor
Taipei Medical University Hospital
Phase
Not applicable
Overall status
Unknown status
Start date
April 21, 2016
Completion date
November 1, 2023
Enrollment
50 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

breast cancer, breast neoplasms, left sided breast cancer